The Centers for Medicare and Medicaid Services proposed a rule to cover obesity drugs under Medicare and Medicaid starting in 2026, potentially benefiting 3.4 million people at a cost of $25 billion over ten years. This historic move reclassifies obesity drugs as treatments for chronic disease, aligning with medical consensus on obesity's health risks. Additionally, the rule aims to enhance transparency in Medicare Advantage plans and improve access to health services.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.